‘Stem cell therapy for autism is illegal’: National Medical Commission issues advisory | Today News
Analysis Summary
- Propaganda Score
- 0% (confidence: 100%)
- Summary
- The National Medical Commission (NMC) issued an advisory declaring stem cell therapy for Autism Spectrum Disorder illegal, aligning with a Supreme Court order. The directive restricts routine use to 32 approved diseases and mandates regulatory compliance for research, citing recommendations from the Indian Council of Medical Research (ICMR).
Fact-Check Results
“National Medical Commission (NMC) has now issued an advisory declaring stem cell therapy illegal for the treatment of Autism Spectrum Disorder in compliance with an order by the Supreme Court.”
❓
INSUFFICIENT EVIDENCE
— No evidence found in archive to verify or contradict the claim about NMC advisory and Supreme Court compliance.
“According to the advisory issued on March 25 to all medical colleges, hospitals and registered medical practitioners, stem cell therapy can now be used only for 32 approved diseases.”
❓
INSUFFICIENT EVIDENCE
— No evidence found in archive to confirm the March 25 advisory or its contents about approved diseases.
“These include Acute Myeloid Leukemia, Multiple Sclerosis, Thalassemia, Osteopetrosis, Multiple Myeloma, Aplastic Anaemia/Paroxysmal hemoglobinuria, Germ Cell tumours and Myelofibrosis.”
❓
INSUFFICIENT EVIDENCE
— No evidence found in archive to verify the list of diseases mentioned in the advisory.
“The advisory has been issued based on the recommendations of the Indian Council of Medical Research (ICMR).”
❓
INSUFFICIENT EVIDENCE
— No evidence found in archive to confirm the advisory's basis on ICMR recommendations.
“The move is aimed at cracking down on illegal practices by private clinics in metropolitan and tier-2 cities that claim to treat autism and cerebral palsy using stem cell therapy – reported news wire PTI – citing sources aware of the matter.”
❓
INSUFFICIENT EVIDENCE
— No evidence found in archive to verify claims about private clinics or PTI reporting.
“The advisory is in compliance with an order by the Supreme Court.”
❓
INSUFFICIENT EVIDENCE
— No evidence found in archive to confirm compliance with a Supreme Court order.
“During a hearing on January 30, the Supreme Court delivered a judgment regarding stem cell therapy, following which ICMR Director General Dr Rajiv Bahl, on March 10, wrote to NMC Chairman Dr Abhijat Sheth, sharing a list of 32 diseases where stem cell therapyＱ can be used.”
❓
INSUFFICIENT EVIDENCE
— No evidence found in archive to verify the timeline or details of the Supreme Court judgment and ICMR communication.
“Any stem cell treatment not included in the list of standard care indications, or not approved by CDSCO or DHR, shall be deemed illegal and liable to action in accordance with law.”
❓
INSUFFICIENT EVIDENCE
— No evidence found in archive to confirm legal status of unapproved stem cell treatments.
“The Supreme Court delivered a judgment on February 3, 2026, regarding the use of stem cell therapy for treating Autism Spectrum Disorder (ASD).”
❓
INSUFFICIENT EVIDENCE
— No evidence found in archive to verify the Supreme Court's February 3, 2026 judgment on ASD treatment.
“Stem cell therapies in routine practice shall be permitted only for disease conditions specified in the list of Union Health Ministry-approved indications as standard care.”
❓
INSUFFICIENT EVIDENCE
— No evidence found in archive to confirm the Union Health Ministry's approved indications for stem cell therapy.
“Stem cell therapy involving cells that have undergone more than minimal manipulation shall be regulated by the Central Drugs Standard Control Organisation (CDSCO).”
❓
PENDING
“Stem cell research must comply with ICMR ethical guidelines, including written informed consent, no cost to the patient, and provision of compensation in case of injury or death.”
❓
PENDING
“An advisory shall be issued restricting routine stem cell therapy practice to the approved indications listed in ICMR/DHR/MoHFW guidelines.”
❓
PENDING
“Stem cell therapy involving cells that have undergone less than minimal manipulation shall be regulated by the Department of Health Research (DHR).”
❓
PENDING
“Stem cell research shall be permissible only as part of an approved clinical trial.”
❓
PENDING
“Clinical trials involving stem cell therapy shall require prior approval from the National Stem Cell Research Regulation Committee, in addition to the Institutional Ethics Committee (IEC) registered with DHR.”
❓
PENDING
“Any deviation from the guidelines regarding stem cell therapy shall be liable to regulatory and legal action in accordance with law.”
❓
PENDING